Verve Therapeutics Balance Sheet

Financials in millions AED. Fiscal year is January - December.

Millions AED. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	548.88	504.3	776.62	200.79	179.54
Short-Term Investments	13.5	12.77	11.51	47.34	78.77
Trading Asset Securities	48.3	65.63	89.14	83.74	78.47
Cash & Short-Term Investments	610.68	582.7	877.26	331.88	336.78
Cash Growth	84.01%	-33.58%	164.34%	-1.46%	-
Accounts Receivable	56.16	58.49	84.34	8.8	1.59
Other Receivables	212.43	172.03	67.09	-	-
Receivables	268.59	230.51	151.42	8.8	1.59
Inventory	275.88	204.43	247.58	144.62	139.04
Prepaid Expenses	24.89	23.96	40.43	9.49	27.3
Other Current Assets	25.62	124.89	258.72	-	-
Total Current Assets	1,206	1,166	1,575	494.79	504.7
Property, Plant & Equipment	1,469	1,444	1,360	571.92	460.96
Long-Term Investments	220.16	246.44	310.53	56.82	52.77
Goodwill	930.01	930.01	1,009	50	50
Other Intangible Assets	31.51	28.98	77.55	-	-
Other Long-Term Assets	1,863	1,857	1,770	1,454	369.68
Total Assets	5,720	5,673	6,103	2,628	1,438
Accounts Payable	358.7	233.7	240.8	122.15	160.28
Accrued Expenses	12.71	9.77	13.42	4.96	12.83
Short-Term Debt	-	-	43.43	-	-
Current Portion of Long-Term Debt	-	13	2.05	51.49	-
Current Portion of Leases	109.34	86.37	65.56	74.33	58.2
Current Unearned Revenue	51.54	42.62	42.55	-	-
Other Current Liabilities	224.41	239.9	215.07	72.01	79.46
Total Current Liabilities	778.13	625.35	622.87	324.93	310.77
Long-Term Debt	-	157.79	723.05	687.34	-
Long-Term Leases	602.58	608.53	560.38	132.91	197.59
Total Liabilities	1,408	1,419	1,940	1,163	528.65
Common Stock	1,115	1,115	899.19	381.4	256.4
Additional Paid-In Capital	2,300	2,300	1,593	289.5	-
Retained Earnings	819.14	770.03	867.47	921.82	787.44
Comprehensive Income & Other	76.76	68.6	803.7	-127.29	-134.39
Shareholders' Equity	4,311	4,254	4,163	1,465	909.46
Total Liabilities & Equity	5,720	5,673	6,103	2,628	1,438
Total Debt	711.92	865.69	1,394	946.06	255.79
Net Cash (Debt)	-101.24	-282.99	-517.2	-614.19	80.99
Net Cash Per Share	-0.05	-0.13	-0.53	-0.81	-
Filing Date Shares Outstanding	2,231	2,231	1,798	762.81	-
Total Common Shares Outstanding	2,231	2,231	1,798	762.81	-
Working Capital	427.52	541.14	952.54	169.86	193.93
Book Value Per Share	1.93	1.91	2.32	1.92	-
Tangible Book Value	3,350	3,295	3,077	1,415	859.46
Tangible Book Value Per Share	1.50	1.48	1.71	1.86	-
Land	-	509.36	453.5	167.46	103.38
Machinery	-	203.5	219.16	121.62	107.95
Construction In Progress	-	151.01	151.43	110.19	26.87
Leasehold Improvements	-	292.88	290.48	249.46	243.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.